|
|
||||||||
J Thorac Cardiovasc Surg 2008;136:448-451
© 2008 The American Association for Thoracic Surgery
Surgery for Acquired Cardiovascular Disease |
Department for Cardiovascular Surgery, University Hospital Berne, Berne, Switzerland
Received for publication August 9, 2007; revisions received October 30, 2007; accepted for publication November 13, 2007. * Address for reprints: Alexander Kadner, MD, Clinic for Cardiovascular Surgery, University Hospital Berne, Freiburgstrasse, 3010 Berne, Switzerland. (Email: alexander.kadner{at}web.de).
| Abstract |
|---|
|
|
|---|
Methods: Between January of 2000 and March of 2007, 25 patients (17 male, mean age 60 years) underwent emergency open embolectomy for central and paracentral pulmonary embolism. Eighteen patients presented in cardiogenic shock, 8 of whom had cardiac arrest and required cardiopulmonary resuscitation. All patients underwent operation with mild hypothermic cardiopulmonary bypass. Concomitant procedures were performed in 8 patients (3 coronary artery bypass grafts, 2 patent foramen ovale closures, 4 ligations of the left atrial appendage, 3 removals of a right atrial thrombus). Follow-up is 96% complete with a median of 2 years (range, 2 months to 6 years).
Results: All patients survived the procedure, but 2 patients died in the hospital on postoperative days 1 (intracerebral bleeding) and 11 (multiorgan failure), accounting for a 30-day mortality of 8% (95% confidence interval: 0.98–0.26). Four patients died later because of their underlying disease. Pre- and postoperative echocardiographic pressure measurements demonstrated the reduction of the pulmonary hypertension to half of the systemic pressure values or less.
Conclusion: Surgical pulmonary embolectomy is an excellent option for patients with major pulmonary embolism and can be performed with minimal mortality and morbidity. Even patients who present with cardiac arrest and require preoperative cardiopulmonary resuscitation show satisfying results. Immediate surgical desobstruction favorably influences the pulmonary pressure and the recovery of right ventricular function, and remains the treatment of choice for patients with massive central and paracentral embolism with hemodynamic and respiratory compromise.
| Introduction |
|---|
|
|
|---|
In contrast, a more aggressive surgical approach to massive pulmonary embolism has been reported by others, who find surgical embolectomy reasonable treatment for massive central and paracentral pulmonary embolism in case of hemodynamic compromise, but also in hemodynamically stable patients with right ventricular dysfunction.5,6
We present our institutional experience with the surgical treatment of central and paracentral pulmonary embolism.
| Materials and Methods |
|---|
|
|
|---|
|
|
|
|
| Results |
|---|
|
|
|---|
All patients survived the procedure. The 30-day mortality was 8% (2 patients) (95% confidence interval [CI]: 0.98–26.03). A 62-year-old female patient died of intracerebral bleeding on postoperative day 1. She was referred after 2 unsuccessful attempts of thrombolysis. A 70-year-old male patient died of aspiration pneumonia and multiorgan failure on postoperative day 11. This patient had also undergone unsuccessful thrombolytic therapy before surgical intervention. Both patients had undergone cardiopulmonary resuscitation and presented preoperatively in profound cardiogenic shock with maximal inotropic support and shock indexes of 3.3 and 2.1, respectively.
Reoperations for mediastinal bleeding were performed in 2 patients (8%). Postoperatively, all patients received anticoagulation therapy starting with heparin 6 hours postoperatively until oral anticoagulation with warfarin was fully effective with a target international normalized ratio between 2.0 and 3.0. No filters were inserted into the inferior vena cava.
The median follow-up interval was 24 months (range, 2–85 months) and is complete in 96% (24 patients). Twelve patients were followed for more than 2 years, 9 patients were followed for more than 3 years, and 7 patients were followed for more than 4 years.
There were 4 late deaths. Actuarial survival at 1 and 4 years' follow-up was 80% (95 CI: 0.61–0.93) at 1 year and 76% (95 CI: 0.54–0.9) at 4 years. All patients with late deaths (at 2, 4, and 5 months, and at 3 years) died of cancer.
Postoperative echocardiographic pressure measurements demonstrated a significant reduction (P < .001) of the pulmonary pressure to half of the systemic values or less in all patients (n = 13) who received preoperative and postoperative echocardiographic evaluation with estimation of the pulmonary artery pressure (
Figure 2). At last follow-up, all patients were classified with New York Heart Association functional class I or II, and no recurrence of pulmonary embolism was observed.
|
| Discussion |
|---|
|
|
|---|
Others suggest a more aggressive approach. Leacche and colleagues6
recommend surgical embolectomy in the presence of large central clot burden in hemodynamically stable patients who show right ventricular dysfunction. They report on 47 patients with an operative mortality rate of 6% (3 patients). Two of their patients had preoperative cardiac arrest, and there were 6 late deaths (12%), mostly from metastatic cancer.
Our observation compares favorably with these data, with all patients surviving the procedure and a 30-day mortality of 8% (2 patients). Both early postoperative deaths were not directly related to surgery; 1 patient died of intracerebral bleeding on postoperative day 1, and 1 patient died of multiorgan failure on postoperative day 11. Both patients had undergone two unsuccessful attempts of thrombolytic therapy.
Both patients who died early in this study had preoperative cardiac arrest, and this underlines the strong negative impact of preoperative cardiac arrest on the operative mortality rate after pulmonary embolectomy. In a recent systematic review of more than 40 reports, Stein and colleagues8
found a 59% operative mortality rate among patients with cardiac arrest before pulmonary embolectomy. In this study, a 29% mortality rate (2 deaths) was found among the 7 patients experiencing preoperative cardiac arrest.
With regard to late death, we observed a 16% late mortality rate caused by the 4 patients' underlying diseases, primarily metastatic cancer.
The cause of early death in patients undergoing pulmonary embolectomy has been largely attributed to right ventricular failure secondary to persistent pulmonary hypertension, interstitial pulmonary edema, and massive parenchymal and intrabronchial hemorrhage.9,10
A proposed explanation is an incomplete removal of thrombotic material from the distal pulmonary arterial tree causing persistent hypertension.
The extraction of distal thrombotic material is commonly attempted by means of Fogarty catheter extraction or manual compression of the lungs. Both methods cannot be well controlled and may cause mechanical injuries to the pulmonary arterial wall, especially in the segmental branches, and may provoke parenchymal and endobronchial bleeding. Spagnolo and colleagues11
proposed retrograde pulmonary perfusion to flush out residual thrombotic material and to prevent pulmonary air embolism by a retrograde filling of the pulmonary artery. We do not find this technique necessary and did not use it in any of our patients. We found pulmonary arterioscopy to be a useful technique to localize and facilitate distal clot extraction. We think that the most complete removal of thrombotic material is the best predictor to avoid persistent pulmonary artery hypertension.
In the situation of more peripherally located clot burden and difficult removal, cooling on CPB of the patient could also be considered to reduce CPB flow for an improved visualization. However, this additional maneuver was not necessary in our patients.
In regard to the postoperative anticoagulation therapy of the patients, heparin was started 6 hours after surgery and continued until warfarin was fully effective with a target international normalized ratio between 2.0 and 3.0. No caval filters were placed postoperatively. Caval filters might prevent recurrent embolism, but patients with filters are prone to develop deep vein thrombosis.12,13
Therefore, the placement of temporary caval filters might be considered in patients who have transient contraindications to anticoagulation therapy and who experience recurrent embolism despite optimal oral anticoagulation.
In contrast with many previous studies, our results confirm that surgical pulmonary embolectomy can be performed with a low mortality rate in patients with massive central and paracentral pulmonary embolism, even in those who experience cardiac arrest before surgical intervention. We think that an essential component for this improved outcome is a multidisciplinary approach with rapid diagnosis by CT and echocardiography. CT helps to identify patients with centrally localized emboli, which are surgically accessible, whereas patients presenting with the majority of the clot burden located more peripherally might not be good candidates for a surgical intervention. Echocardiography allows the identification of patients with impending right ventricular dysfunction, which has been shown to be a strong risk factor for death.
In view of the low mortality rate revealed by more recent reports, including the present one, and the lower number of hemorrhagic events and lower rate of recurrent pulmonary embolic events when compared with medical treatment in hemodynamically compromised patients, surgical embolectomy should not be reserved for patients with massive pulmonary embolism who present in cardiogenic shock, as advocated in the past. Unfortunately, the Trendelenburg procedure (using inflow occlusion without CPB) might still be considered by emergency department doctors. However, this is a heroic surgical intervention that has nothing in common with the meticulous extraction of the thrombotic material, as currently practiced.
| Conclusions |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. Taniguchi, W. Fukuda, I. Fukuda, K.-i. Watanabe, Y. Saito, M. Nakamura, and M. Sakuma Outcome of pulmonary embolectomy for acute pulmonary thromboembolism: analysis of 32 patients from a multicentre registry in Japan Interact CardioVasc Thorac Surg, January 1, 2012; 14(1): 64 - 67. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Fukuda, S. Taniguchi, K. Fukui, M. Minakawa, K. Daitoku, and Y. Suzuki Improved Outcome of Surgical Pulmonary Embolectomy by Aggressive Intervention for Critically Ill Patients Ann. Thorac. Surg., March 1, 2011; 91(3): 728 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kawahito and H. Adachi Balloon Catheter Pulmonary Embolectomy Under Direct Visual Control Using a Choledochoscope Ann. Thorac. Surg., February 1, 2011; 91(2): 621 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Vohra, R. N. Whistance, K. Mattam, M. Kaarne, M. P. Haw, C. W. Barlow, G. M. K. Tsang, S. A. Livesey, and S. K. Ohri Early and Late Clinical Outcomes of Pulmonary Embolectomy for Acute Massive Pulmonary Embolism Ann. Thorac. Surg., December 1, 2010; 90(6): 1747 - 1752. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Masroor Invited Commentary Ann. Thorac. Surg., December 1, 2010; 90(6): 1752 - 1752. [Full Text] [PDF] |
||||
![]() |
G. Samoukovic, T. Malas, and B. de Varennes The role of pulmonary embolectomy in the treatment of acute pulmonary embolism: a literature review from 1968 to 2008 Interact CardioVasc Thorac Surg, September 1, 2010; 11(3): 265 - 270. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |